JFNIX
Price
$67.12
Change
-$0.85 (-1.25%)
Updated
Apr 3 closing price
Net Assets
4.95B
LHCQX
Price
$17.48
Change
-$0.42 (-2.35%)
Updated
Apr 3 closing price
Net Assets
7.48M
Ad is loading...

JFNIX vs LHCQX

Header iconJFNIX vs LHCQX Comparison
Open Charts JFNIX vs LHCQXBanner chart's image
Janus Henderson Global Life Sciences I
Price$67.12
Change-$0.85 (-1.25%)
VolumeN/A
Net Assets4.95B
Lord Abbett Health Care R3
Price$17.48
Change-$0.42 (-2.35%)
VolumeN/A
Net Assets7.48M
JFNIX vs LHCQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCQX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.95B vs. LHCQX (7.48M). JFNIX pays higher dividends than LHCQX: JFNIX (0.39) vs LHCQX (0.36). JFNIX was incepted earlier than LHCQX: JFNIX (16 years) vs LHCQX (6 years). LHCQX (3.78) is less costly to investors than JFNIX (0.77). LHCQX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCQX has a lower initial minimum investment than JFNIX: LHCQX (0) vs JFNIX (2500). LHCQX annual gain was more profitable for investors over the last year : -3.92 vs. JFNIX (-6.78). JFNIX return over 5 years is better than : 35.56 vs. LHCQX (29.01).
JFNIXLHCQXJFNIX / LHCQX
Total Expense Ratio0.771.2860%
Annual Report Gross Expense Ratio0.773.7820%
Fund Existence16 years6 years-
Gain YTD-0.074-5.1911%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.95B7.48M66,114%
Annual Yield % from dividends0.390.36109%
Returns for 1 year-6.78-3.92173%
Returns for 3 years2.62-2.45-107%
Returns for 5 years35.5629.01123%
Returns for 10 years19.10N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHCX86.88N/A
N/A
Rydex Health Care C
FKEMX38.01N/A
N/A
Fidelity Emerging Markets K
DLQIX14.09N/A
N/A
BNY Mellon Large Cap Equity I
NRAAX47.86N/A
N/A
Neuberger Berman Sustainable Equity A
SCVJX35.07N/A
N/A
Allspring Small Company Value R6